George C Eckert Ii
Examiner (ID: 117)
Most Active Art Unit | 2815 |
Art Unit(s) | 2815 |
Total Applications | 416 |
Issued Applications | 363 |
Pending Applications | 8 |
Abandoned Applications | 45 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14553689
[patent_doc_number] => 10345296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-09
[patent_title] => Device and method for biomarker detection
[patent_app_type] => utility
[patent_app_number] => 15/679413
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 9948
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15679413
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/679413 | Device and method for biomarker detection | Aug 16, 2017 | Issued |
Array
(
[id] => 13942531
[patent_doc_number] => 10207010
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-19
[patent_title] => Compositions and methods for delivery of agents
[patent_app_type] => utility
[patent_app_number] => 15/674872
[patent_app_country] => US
[patent_app_date] => 2017-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 123
[patent_figures_cnt] => 159
[patent_no_of_words] => 104055
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674872
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/674872 | Compositions and methods for delivery of agents | Aug 10, 2017 | Issued |
Array
(
[id] => 12766390
[patent_doc_number] => 20180147298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/674107
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674107
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/674107 | Compositions and methods for delivery of agents | Aug 9, 2017 | Issued |
Array
(
[id] => 13856925
[patent_doc_number] => 10190174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Ulcerative colitis (UC)-associated colorectal neoplasia markers
[patent_app_type] => utility
[patent_app_number] => 15/672778
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 27162
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15672778
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/672778 | Ulcerative colitis (UC)-associated colorectal neoplasia markers | Aug 8, 2017 | Issued |
Array
(
[id] => 13856817
[patent_doc_number] => 10190120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Zn-DPA complex compounds and siRNA delivery systems containing the same
[patent_app_type] => utility
[patent_app_number] => 15/671901
[patent_app_country] => US
[patent_app_date] => 2017-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 6573
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15671901
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/671901 | Zn-DPA complex compounds and siRNA delivery systems containing the same | Aug 7, 2017 | Issued |
Array
(
[id] => 12159239
[patent_doc_number] => 20180030505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'USE OF APTAMERS IN PROTEOMICS'
[patent_app_type] => utility
[patent_app_number] => 15/669782
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9147
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15669782
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/669782 | Use of aptamers in proteomics | Aug 3, 2017 | Issued |
Array
(
[id] => 14306473
[patent_doc_number] => 20190142940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => Method and system for effecting changes in pigmented tissue
[patent_app_type] => utility
[patent_app_number] => 15/731805
[patent_app_country] => US
[patent_app_date] => 2017-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15731805
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/731805 | Method and system for effecting changes in pigmented tissue | Aug 2, 2017 | Abandoned |
Array
(
[id] => 14806121
[patent_doc_number] => 20190269670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => COMPOUNDS AND METHODS OF PROMOTING MYELINATION
[patent_app_type] => utility
[patent_app_number] => 16/320554
[patent_app_country] => US
[patent_app_date] => 2017-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320554
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320554 | Compounds and methods of promoting myelination | Jul 26, 2017 | Issued |
Array
(
[id] => 12159176
[patent_doc_number] => 20180030442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'MICRORNA THERAPY FOR PANCREATIC CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/660403
[patent_app_country] => US
[patent_app_date] => 2017-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 9306
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660403
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/660403 | MicroRNA therapy for pancreatic cancer | Jul 25, 2017 | Issued |
Array
(
[id] => 13814725
[patent_doc_number] => 10184123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-22
[patent_title] => RNA targeting in alpha-synucleinopathies
[patent_app_type] => utility
[patent_app_number] => 15/651462
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 16
[patent_no_of_words] => 6064
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651462
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/651462 | RNA targeting in alpha-synucleinopathies | Jul 16, 2017 | Issued |
Array
(
[id] => 15039309
[patent_doc_number] => 20190330659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => SCARLESS DNA ASSEMBLY AND GENOME EDITING USING CRISPR/CPF1 AND DNA LIGASE
[patent_app_type] => utility
[patent_app_number] => 16/310895
[patent_app_country] => US
[patent_app_date] => 2017-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20231
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310895
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/310895 | SCARLESS DNA ASSEMBLY AND GENOME EDITING USING CRISPR/CPF1 AND DNA LIGASE | Jul 13, 2017 | Abandoned |
Array
(
[id] => 12791647
[patent_doc_number] => 20180155718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => RNA DUPLEXES WITH SINGLE STRANDED PHOSPHOROTHIOATE NUCLEOTIDE REGIONS FOR ADDITIONAL FUNCTIONALITY
[patent_app_type] => utility
[patent_app_number] => 15/638586
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15638586
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/638586 | RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality | Jun 29, 2017 | Issued |
Array
(
[id] => 12119153
[patent_doc_number] => 20180002740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'TRANSCRIPTION FACTOR DECOYS, COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/635801
[patent_app_country] => US
[patent_app_date] => 2017-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 40222
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15635801
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/635801 | TRANSCRIPTION FACTOR DECOYS, COMPOSITIONS AND METHODS | Jun 27, 2017 | Abandoned |
Array
(
[id] => 14243859
[patent_doc_number] => 10272112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoimmune therapies
[patent_app_type] => utility
[patent_app_number] => 15/635007
[patent_app_country] => US
[patent_app_date] => 2017-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 64
[patent_no_of_words] => 30470
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15635007
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/635007 | Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoimmune therapies | Jun 26, 2017 | Issued |
Array
(
[id] => 14948993
[patent_doc_number] => 10435757
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-10-08
[patent_title] => Methods of measuring C19MC miRNA in a post-natal tissue and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/623832
[patent_app_country] => US
[patent_app_date] => 2017-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8429
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15623832
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/623832 | Methods of measuring C19MC miRNA in a post-natal tissue and uses thereof | Jun 14, 2017 | Issued |
Array
(
[id] => 14439709
[patent_doc_number] => 20190177727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => METHODS FOR DIAGNOSING AND TREATING METASTATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 16/309800
[patent_app_country] => US
[patent_app_date] => 2017-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309800
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309800 | Methods for diagnosing and treating metastatic cancer | Jun 13, 2017 | Issued |
Array
(
[id] => 13717851
[patent_doc_number] => 20170369880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => COMPOSITIONS COMPRISING ALTERNATING 2'-MODIFIED NUCLEOSIDES FOR USE IN GENE MODULATION
[patent_app_type] => utility
[patent_app_number] => 15/623193
[patent_app_country] => US
[patent_app_date] => 2017-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15623193
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/623193 | Compositions comprising alternating 2'-modified nucleosides for use in gene modulation | Jun 13, 2017 | Issued |
Array
(
[id] => 12751216
[patent_doc_number] => 20180142239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER OR OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/623187
[patent_app_country] => US
[patent_app_date] => 2017-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15623187
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/623187 | Methods and compositions for the treatment of cancer or other diseases | Jun 13, 2017 | Issued |
Array
(
[id] => 17633926
[patent_doc_number] => 11344631
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Promoter for cell-specific gene expression and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/308446
[patent_app_country] => US
[patent_app_date] => 2017-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9663
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308446
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308446 | Promoter for cell-specific gene expression and uses thereof | Jun 11, 2017 | Issued |
Array
(
[id] => 12980614
[patent_doc_number] => 20170342413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => ANTISENSE DESIGN
[patent_app_type] => utility
[patent_app_number] => 15/619134
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15619134
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/619134 | Antisense design | Jun 8, 2017 | Issued |